TOP

Research Article

Split Viewer

Mol. Cells 2002; 14(1): 115-121

Published online January 1, 1970

© The Korean Society for Molecular and Cellular Biology

Interleukin-4 Inhibits the Vascular Endothelial Growth Factor- and Basic Fibroblast Growth Factor-induced Angiogenesis in vitro

In Yong Lee, Jinkoo Kim, Eun-Mi Ko, Euh Jun Jeoung, Young-Guen Kwon, Jongseon Choe

Abstract

The role of interleukin-4 (IL-4) in the inflammatory process has emerged recently. In this study, we investi-gated the effect of IL-4 on the angiogenic process in an in vitro experimental system. IL-4 significantly inhib-ited the proliferation of human umbilical vein endothelial cells (HUVEC) that was induced by the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). VEGF- or bFGF-induced HUVEC chemotaxis was abrogated by the IL-4 treatment. In addition, the formation of tube-like structures by HUVEC in the presence of VEGF or bFGF was also severely down-regulated by IL-4. The inhibitory effects on the critical steps of angiogenesis were not observed with IL-6 that is abundantly found in the inflamed tissue. Our results suggest that IL-4 may play a regulatory role in normal physiology and provide the potential possibility for IL-4 as a thera-peutic agent in the intervention of angiogenesis-related diseases.

Keywords bFGF, IL-4, VEGF., Angiogenesis

Article

Research Article

Mol. Cells 2002; 14(1): 115-121

Published online August 31, 2002

Copyright © The Korean Society for Molecular and Cellular Biology.

Interleukin-4 Inhibits the Vascular Endothelial Growth Factor- and Basic Fibroblast Growth Factor-induced Angiogenesis in vitro

In Yong Lee, Jinkoo Kim, Eun-Mi Ko, Euh Jun Jeoung, Young-Guen Kwon, Jongseon Choe

Abstract

The role of interleukin-4 (IL-4) in the inflammatory process has emerged recently. In this study, we investi-gated the effect of IL-4 on the angiogenic process in an in vitro experimental system. IL-4 significantly inhib-ited the proliferation of human umbilical vein endothelial cells (HUVEC) that was induced by the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). VEGF- or bFGF-induced HUVEC chemotaxis was abrogated by the IL-4 treatment. In addition, the formation of tube-like structures by HUVEC in the presence of VEGF or bFGF was also severely down-regulated by IL-4. The inhibitory effects on the critical steps of angiogenesis were not observed with IL-6 that is abundantly found in the inflamed tissue. Our results suggest that IL-4 may play a regulatory role in normal physiology and provide the potential possibility for IL-4 as a thera-peutic agent in the intervention of angiogenesis-related diseases.

Keywords: bFGF, IL-4, VEGF., Angiogenesis

Mol. Cells
Nov 30, 2023 Vol.46 No.11, pp. 655~725
COVER PICTURE
Kim et al. (pp. 710-724) demonstrated that a pathogen-derived Ralstonia pseudosolanacearum type III effector RipL delays flowering time and enhances susceptibility to bacterial infection in Arabidopsis thaliana. Shown is the RipL-expressing Arabidopsis plant, which displays general dampening of the transcriptional program during pathogen infection, grown in long-day conditions.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download